SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How AI will transform mental health support for patients with breast cancer

2.

Asymptomatic or Minimally Symptomatic Myelofibrosis

3.

Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.

4.

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

5.

High Rate of Deep Remission for Relapsed/Refractory CLL Using Triple Regimen.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot